Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/CIMA-AEMPS/ZOMIG FLAS 2,5 MG COMPRIMIDOS BUCODISPERSABLES

Approved

STANDARD

ZOMIG FLAS 2,5 MG COMPRIMIDOS BUCODISPERSABLES

Laboratoires Grunenthal🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: May 14, 2025
Approval ID: 6a97d7df12811169
Company: Laboratoires Grunenthal
Type: Standard

Approval Details

Approval Id: 6a97d7df12811169
Drug Cima Aemps Name: ZOMIG FLAS 2,5 MG COMPRIMIDOS BUCODISPERSABLES
Register Number: 3400935336651IP
Holder Company Name: Laboratoires Grunenthal
Marketing Company Name: Melyfarma S.L.
Authorization Date: 2025-05-14
Dosage Form: COMPRIMIDO BUCODISPERSABLE
Dose: 2,5 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Laboratoires Grunenthal

Active Ingredients

ZOLMITRIPTAN

2,5 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

May 14, 2025

Approval ID

6a97d7df12811169

Type

Standard

Back to CIMA-AEMPS Approvals

ZOMIG FLAS 2,5 MG COMPRIMIDOS BUCODISPERSABLES - CIMA-AEMPS Drug Approval Details